Events . News . Articles

The Feed

Apr 4, 20221 min read

CEO - Dror Chevion, gives Keynote speech and awarded Health 2.0 Outstanding Leadership Award (Dubai)

CEO Dror Chevion gave a KEYNOTE speech at the Health 2.0 Conference which attempts to reimagine the realm of healthcare by uniting some...

Jan 30, 20222 min read

"First-In-Man Clinical Trial – Zygosid-50 for treating T2D" - summary of results (partial)

The primary efficacy objective of the study was to demonstrate that treatment with Zygosid-50 yields a significant reduction in the...

Aug 5, 20212 min read

First Patient Dosed in Clinical Trial!

Glucometer

May 24, 20211 min read

Our CLINICAL TRIAL is now Recruiting Type 2 Diabetes Patients

Concenter Biopharma, together with the SHEBA Medical Center in Israel recently began recruiting patients for the clinical trial using the...

May 2, 20211 min read

WINNERS OF THE 2021 BIOTECHNOLOGY AWARDS

Concenter BioPharma chosen as WINNERS OF THE 2021 BIOTECHNOLOGY AWARDS

Mar 7, 20211 min read

"Zycords" – Patent GRANTED by EPO!

The ZYCORDS patent was recently granted by the European Patent Office and was validated in major European countries.